# A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

> clinical trial · VERIFIED · 2026-06-12

Status: RECRUITING · Sponsor: argenx · Condition: Immune Thrombocytopenia (ITP)

- Company: argenx
- Sector: hematology
- Primary source: https://clinicaltrials.gov/study/NCT07194850

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.